Chu, K.-B.; Kang, H.-J.; Yoon, K.-W.; Lee, H.-A.; Moon, E.-K.; Han, B.-K.; Quan, F.-S.
Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 Domains. Vaccines 2021, 9, 920.
https://doi.org/10.3390/vaccines9080920
AMA Style
Chu K-B, Kang H-J, Yoon K-W, Lee H-A, Moon E-K, Han B-K, Quan F-S.
Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 Domains. Vaccines. 2021; 9(8):920.
https://doi.org/10.3390/vaccines9080920
Chicago/Turabian Style
Chu, Ki-Back, Hae-Ji Kang, Keon-Woong Yoon, Hae-Ahm Lee, Eun-Kyung Moon, Beom-Ku Han, and Fu-Shi Quan.
2021. "Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 Domains" Vaccines 9, no. 8: 920.
https://doi.org/10.3390/vaccines9080920
APA Style
Chu, K.-B., Kang, H.-J., Yoon, K.-W., Lee, H.-A., Moon, E.-K., Han, B.-K., & Quan, F.-S.
(2021). Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 Domains. Vaccines, 9(8), 920.
https://doi.org/10.3390/vaccines9080920